Differential response between diabetes and stress-induced hyperglycaemia to algorithmic use of detemir and flexible mealtime aspart among stable postcardiac surgery patients requiring intravenous insulin

Diabetes, Obesity and Metabolism

Volumn 13, Issue 12, 2011, Pages 1130-1135

  Dungan, K ^a   Hall, C ^a   Schuster, D ^a   Osei, K ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Adipose tissue; Antidiabetic drug; Antiobesity drug; Bariatric surgery; Beta cell; Diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN DETEMIR;

ADULT; ARTICLE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART SURGERY; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; STRESS INDUCED HYPERGLYCEMIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 80055037046     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2011.01474.x     Document Type: Article

References (19)

1. Knapik P, Nadziakiewicz P, Urbanska E, Saucha W, Herdynska M, Zembala M. Cardiopulmonary bypass increases postoperative glycemia and insulin consumption after coronary surgery. Ann Thorac Surg 2009; 87: 1859-1865.
2. Donatelli F, Cavagna P, Di Dedda G et al. Correlation between pre-operative metabolic syndrome and persistent blood glucose elevation during cardiac surgery in non-diabetic patients. Acta Anaesthesiol Scand 2008; 52: 1103-1110.
3. Arora S, Gordon MB. High incidence of impaired glucose regulation in patients with no known history of diabetes mellitus but with hyperglycemia after undergoing a cardiac surgical procedure. Endocr Pract 2009; 15: 425-430.
4. Tekumit H, Cenal AR, Polat A, Uzun K, Tataroglu C, Akinci E. Diagnostic value of hemoglobin A1c and fasting plasma glucose levels in coronary artery bypass grafting patients with undiagnosed diabetes mellitus. Ann Thorac Surg 2010; 89: 1482-1487.
5. Schmeltz LR, DeSantis AJ, Thiyagarajan V et al. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care 2007; 30: 823-828.
6. Duncan AE, Abd-Elsayed A, Maheshwari A, Xu M, Soltesz E, Koch CG. Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery. Anesthesiology 2010; 112: 860-871.
7. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 2004; 10(Suppl. 2): 21-33.
8. Moghissi ES, Korytkowski MT, DiNardo M et al. American Association of Clinical Endocrinologists and American Diabetes Association Consensus statement on inpatient glycemic control. Endocr Pract 2009; 15: 353-369.
9. Bode BW, Braithwaite SS, Steed RD, Davidson PC. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract 2004; 10(Suppl. 2): 71-80.
10. Furnary AP, Braithwaite SS. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol 2006; 98: 557-564.
11. Dungan KM, Braithwaite SS, Preiser J. Stress hyperglycemia. Lancet 2009; 373: 798-807.
12. Dungan KM, Hall C, Schuster D, Osei K. Comparison of three algorithms for basal insulin in transitioning stable post-cardiothoracic surgery patients from intravenous to subcutaneous insulin. Endocr Pract 2011 [Epub ahead of print].
13. Goldberg PA. Memoirs of a root canal salesman: the successful implementation of a hospital-wide intravenous insulin infusion protocol. Endocr Pract 2006; 12(Suppl. 3): 79-85.
14. Kovatchev BP, Otto E, Cox D. Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 2006; 29: 2433-2438.
15. Olansky L, Sam S, Lober C, Yared JP, Hoogwerf B. Cleveland clinic cardiovascular intensive care unit insulin conversion protocol. J Diabetes Sci Technol 2009; 3: 478-486.
16. Murata GH, Duckworth WC, Shah JH, Wendel CS, Hoffman RM. Sources of glucose variability in insulin-treated type 2 diabetes: the diabetes outcomes in veterans study (DOVES). Clin Endocrinology 2004; 60: 451-456.
17. Braithwaite SS. The transition from insulin infusions to long-term diabetes therapy: the argument for insulin analogs. Semin Thorac Cardiovasc Surg 2006; 18: 366-378.
18. Albacker T, Carvalho G, Schricker T, Lachapelle K. High-dose insulin therapy attentuates systemic inflammatory response in coronary artery bypass grafting patients. Ann Thorac Surg 2008; 86: 20-27.
19. Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J. Performance of glycated hemoglobin for the classification and prediction of diabetes. Diabetes Care 2011; 34: 84-89.